Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1792 | 2016 |
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa CC Zouboulis, N Desai, L Emtestam, RE Hunger, D Ioannides, I Juhász, ... Journal of the European Academy of Dermatology and Venereology 29 (4), 619-644, 2015 | 1148 | 2015 |
Hidradenitis suppurativa GBE Jemec New England Journal of Medicine 366 (2), 158-164, 2012 | 1086* | 2012 |
The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries FJ Dalgard, U Gieler, L Tomas-Aragones, L Lien, F Poot, GBE Jemec, ... Journal of Investigative Dermatology 135 (4), 984-991, 2015 | 939 | 2015 |
Two phase 3 trials of adalimumab for hidradenitis suppurativa AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ... New England Journal of Medicine 375 (5), 422-434, 2016 | 668 | 2016 |
The prevalence of hidradenitis suppurativa and its potential precursor lesions GBE Jemec, M Heidenheim, NH Nielsen Journal of the American Academy of Dermatology 35 (2), 191-194, 1996 | 644 | 1996 |
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity K Sartorius, L Emtestam, GBE Jemec, J Lapins British journal of dermatology 161 (4), 831-839, 2009 | 623 | 2009 |
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ... Annals of internal medicine 157 (12), 846-855, 2012 | 515 | 2012 |
Handbook of non-invasive methods and the skin J Serup, GBE Jemec, GL Grove CRC press, 2006 | 470 | 2006 |
What causes hidradenitis suppurativa? L Ralf Paus, H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ... Experimental dermatology 17 (5), 455-456, 2008 | 450 | 2008 |
Hidradenitis suppurativa: advances in diagnosis and treatment DML Saunte, GBE Jemec Jama 318 (20), 2019-2032, 2017 | 445 | 2017 |
Hidradenitis suppurativa R Sabat, GBE Jemec, Ł Matusiak, AB Kimball, E Prens, K Wolk Nature Reviews Disease Primers 6 (1), 18, 2020 | 430 | 2020 |
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa GBE Jemec, P Wendelboe Journal of the American Academy of Dermatology 39 (6), 971-974, 1998 | 428 | 1998 |
Efficacy and safety of oral alitretinoin (9‐cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized … T Ruzicka, CW Lynde, GBE Jemec, T Diepgen, J Berth‐Jones, ... British Journal of Dermatology 158 (4), 808-817, 2008 | 427 | 2008 |
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema JM Jungersted, H Scheer, M Mempel, H Baurecht, L Cifuentes, JK Høgh, ... Allergy 65 (7), 911-918, 2010 | 426 | 2010 |
Morbidity in patients with hidradenitis suppurativa JM Von der Werth, GBE Jemec British journal of dermatology 144 (4), 809-813, 2001 | 392 | 2001 |
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity CC Zouboulis, T Tzellos, A Kyrgidis, GBE Jemec, FG Bechara, ... British Journal of Dermatology 177 (5), 1401-1409, 2017 | 388 | 2017 |
Diagnostic delay in hidradenitis suppurativa is a global problem DM Saunte, J Boer, A Stratigos, JC Szepietowski, I Hamzavi, KH Kim, ... British journal of dermatology 173 (6), 1546-1549, 2015 | 380 | 2015 |
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors IM Miller, C Ellervik, S Yazdanyar, GBE Jemec Journal of the American Academy of Dermatology 69 (6), 1014-1024, 2013 | 351 | 2013 |
Psychosocial impact of hidradenitis suppurativa: a qualitative study S Esmann, GBE Jemec Acta dermato-venereologica 91 (3), 328-332, 2011 | 350 | 2011 |